Current Proteomics
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 4
Author(s): Norelle Daly
Affiliation:
Export Options
About this article
Cite this article as:
Daly Norelle, Meet Our Editorial Board Member, Current Proteomics 2016; 13 (4) . https://dx.doi.org/10.2174/157016461304161230215817
DOI https://dx.doi.org/10.2174/157016461304161230215817 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Air Pollution and Lung Cancer
Current Respiratory Medicine Reviews Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Recent Patents on Anti-Cancer Drug Discovery Fastidious Anatomization of Biota Procured Compounds on Cancer Drug Discovery
Current Pharmaceutical Biotechnology Imaging of Abdominal Aortic Aneurysm: The Present and the Future
Current Vascular Pharmacology Editorial
Anti-Cancer Agents in Medicinal Chemistry Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology Mediterrranean Diet and Health Biological Importance of Olive Oil
Current Pharmaceutical Design MicroRNA and HER2-overexpressing Cancer
MicroRNA Tools For Decision-Making In Older Cancer Patients. Role Of The Comprehensive Geriatric Assessment
Anti-Cancer Agents in Medicinal Chemistry Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells
Letters in Drug Design & Discovery Intra- and Interdomain Flexibility in Matrix Metalloproteinases: Functional Aspects and Drug Design
Current Pharmaceutical Design Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor
Current Drug Targets Nanoparticles Improve Biological Functions of Phthalocyanine Photosensitizers Used for Photodynamic Therapy
Current Drug Metabolism Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment
Current Pharmaceutical Design Attenuating Muscle Wasting: Cell and Gene Therapy Approaches
Current Genomics Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets